US Patent Number

4394390

Publication Date

7-19-1983

Abstract

The invention relates to a novel method of administering propranolol, a known β-adrenergic blocking agent widely used in the treatment of angina pectoris, arrhythmias, hypertension and other cardiac conditions, and migraine. The invention further relates to novel dosage forms of propranolol which are adapted for nasal administration and which include solutions, suspensions, gels and ointments.

Assignees

University of Kentucky Research Foundation, Lexington, Ky.

Application Number

194,786

Filing Date

10/07/1980

Share

COinS